Cargando…
Worsening of the Toxic Effects of (±)Cis-4,4′-DMAR Following Its Co-Administration with (±)Trans-4,4′-DMAR: Neuro-Behavioural, Physiological, Immunohistochemical and Metabolic Studies in Mice
4,4’-Dimethylaminorex (4,4’-DMAR) is a new synthetic stimulant, and only a little information has been made available so far regarding its pharmaco-toxicological effects. The aim of this study was to investigate the effects of the systemic administration of both the single (±)cis (0.1–60 mg/kg) and...
Autores principales: | Tirri, Micaela, Frisoni, Paolo, Bilel, Sabrine, Arfè, Raffaella, Trapella, Claudio, Fantinati, Anna, Corli, Giorgia, Marchetti, Beatrice, De-Giorgio, Fabio, Camuto, Cristian, Mazzarino, Monica, Gaudio, Rosa Maria, Serpelloni, Giovanni, Schifano, Fabrizio, Botrè, Francesco, Marti, Matteo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395767/ https://www.ncbi.nlm.nih.gov/pubmed/34445476 http://dx.doi.org/10.3390/ijms22168771 |
Ejemplares similares
-
Genotoxicological Characterization of (±)cis-4,4′-DMAR and (±)trans-4,4′-DMAR and Their Association
por: Lenzi, Monia, et al.
Publicado: (2022) -
In Vivo Bio-Activation of JWH-175 to JWH-018: Pharmacodynamic and Pharmacokinetic Studies in Mice
por: Tirri, Micaela, et al.
Publicado: (2022) -
Effect of -NBOMe Compounds on Sensorimotor, Motor, and Prepulse Inhibition Responses in Mice in Comparison With the 2C Analogs and Lysergic Acid Diethylamide: From Preclinical Evidence to Forensic Implication in Driving Under the Influence of Drugs
por: Tirri, Micaela, et al.
Publicado: (2022) -
Synthetic cannabinoid JWH-073 alters both acute behavior and in vivo/vitro electrophysiological responses in mice
por: Barbieri, Mario, et al.
Publicado: (2022) -
Revealing the Mechanisms
of Byu dMar 25 in the Treatment
of Alzheimer’s Disease through Network Pharmacology, Molecular
Docking, and In Vivo Experiment
por: Du, Yikuan, et al.
Publicado: (2023)